Hennessy Balanced Investor holds a quantitatively derived Negative Morningstar Medalist Rating. The rating indicates the model sees limited potential for the strategy to outperform peers on a risk-adjusted basis over a full market cycle.
Hennessy Balanced Fund Investor Class HBFBX
- NAV / 1-Day Return 13.29 / −0.75 %
- Total Assets 13.8M
-
Adj. Expense Ratio
1.880%
- Expense Ratio 1.880%
- Distribution Fee Level High
- Share Class Type No Load
- Category Moderately Conservative Allocation
- Investment Style Large Value
- Credit Quality / Interest Rate Sensitivity —
- Status Open
- TTM Yield 1.77%
- Turnover 39%
USD | NAV as of Jun 18, 2026 | 1-Day Return as of Jun 18, 2026, 12:53 AM GMT+0
Morningstar’s Analysis HBFBX
Will HBFBX outperform in the future?
Get our overall rating based on a fundamental assessment of the pillars below.
People Pillar
The People Pillar is our evaluation of the HBFBX management team’s experience and ability. We find that high-quality management teams deliver superior performance relative to their benchmarks and/or peers.
Parent Pillar
The Parent Pillar is our rating of HBFBX’s parent organization’s priorities and whether they’re in line with investors’ interests.
- Current Portfolio Date
- Equity Holdings —
- Bond Holdings —
- Other Holdings —
- % Assets in Top 10 Holdings 46.3
|
Top 10 Holdings
|
% Portfolio Weight
|
Market Value USD
|
Sector
|
|---|---|---|---|
United States Treasury Bills 0% | 14.39 | 2M | Government |
United States Treasury Bills 0% | 13.78 | 2M | Government |
United States Treasury Bills 0% | 10.97 | 1M | Government |
United States Treasury Bills 0% | 7.87 | 1M | Government |
Merck & Co Inc | 6.91 | 938,262 | Healthcare |
Chevron Corp | 6.40 | 868,980 | Energy |
Verizon Communications Inc | 5.18 | 702,800 | Communication Services |
Amgen Inc | 5.05 | 686,108 | Healthcare |
Coca-Cola Co | 4.85 | 657,832 | Consumer Defensive |
Johnson & Johnson | 4.50 | 611,100 | Healthcare |
United States